Abstract Body

Background:

Hepatitis B surface antigen (HBsAg) loss defines a functional cure for chronic hepatitis B infection. Herein, we aimed to characterize circulating HBsAg-specific B cells and identify B-cell epitopes directly associated with HBsAg loss.

Methods:

Seventy-eight treatment-naïve patients with chronic HBV infection were classified into 4 groups according to the EASL guidelines (2017): hepatitis B e antigen (HBeAg) negative chronic infection (n=21), HBeAg-positive chronic infection (n=20), HBeAg-negative chronic hepatitis (n=17), and HBeAg-positive chronic hepatitis (n=20). Forty-six patients who achieved HBsAg loss (n=24) or seroconversion (n=22) following antiviral treatment and 16 hepatitis B vaccinees with normal alanine aminotransferase levels were enrolled. HBsAg-specific B cells phenotypes and function were analyzed by flow cytometry. ELISpot assay was used to measure the ability of B cells to secrete antibodies. HBsAg specific B-cell epitopes associated with functional cure were mapped by ELISA.

Results:

The classical resting memory B cell population (RM, CD21+CD27+) in HBsAg-specific B cells was reduced while the proportion of atypical memory B cells (AtM, CD21–CD27–), a functionally exhausted subset, was expanded in chronically HBV-infected patients. An increased proportion of RM B cells and a deceased proportion of AtM B cells were observed in patients after achieving functional cure. There was no correlation between total HBsAg-specific B cells and virological parameters, but we found an inverse correlation between HBsAg levels and HBsAg-specific RM B-cell frequency. Moreover, HBsAg-specific B cells expressed lower levels of CD32 and higher levels of IL-6 upon stimulation in patients with HBsAg loss. Intriguingly, the frequency of HBsAb-secreting B cells was significantly increased after achieving functional cure. Sera from patients with HBsAg loss mainly reacted with peptides S60, S61, and S76, suggesting that they are dominant linear B-cell epitopes relevant for functional cure. Notably, an expansion of HBsAg-specific B cell was detected in S76-reactive subjects, accompanied by lower PD-1 expression.

Conclusions:

HBsAg-specific B cells were partially restored in patients after achieving functional cure. Functional cure-related epitopes are promising targets of therapeutic vaccine development for chronic HBV infection to increase the functional cure rate.